The Union Health Ministry has recommended use of anti-HIV drug combinations Lopinavir and Ritonavir on a case-to-case basis depending upon the severity of the condition of a patient having coronavirus infection. There is no current evidence from randomised controlled trial to recommend any specific treatment for suspected or confirmed patients with COVID-19.